Market Overview Competitive dynamics are intensifying across the Aarskog Scott Syndrome Treatment Market as established pharmaceutical and rare disease therapy companies pursue innovation and geographic expansion. The market is experiencing targeted growth driven by increasing genetic diagnostic capabilities, rising awareness of X-linked recessive disorders, and expanding research into FGD1...